Dr. Acharya’s research focuses on the design and implementation of epidemiological studies to determine risk factors impacting clinical outcomes in ocular inflammatory disease, and clinical trials to determine the optimal treatment for these conditions. Current projects include epidemiological studies on immunosuppressive therapies, juvenile idiopathic arthritis-associated uveitis, sarcoidosis, smoking and uveitis, and clinical trials on corneal ulcers and uveitis.
Dr. Gonzales's interest involves the diagnosis and management of infectious and non-infectious inflammatory conditions of the eyes (uveitis). Many ocular inflammatory diseases are part of a systemic disorder and require a complete review of one’s health, personalized treatment, and close monitoring. Working as a team with a patient’s rheumatologist, internist, pediatrician, or other subspecialists ensure that his patients receive optimum care.
Dr. Shantha worked from 2015-2017 in West Africa, where the magnitude of the challenges of treating uveitis and ocular inflammation due to resource requirements and disease complexity become apparent. Her career goal is to impact the blinding consequences of unrecognized or untreated uveitis in resource-limited settings. Dr. Shantha is most proud of the ability to advocate for the thousands of Ebola virus survivors that need eye care and routine screenings.
